Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) is planning to close merger and acquisition deals in the third quarter of 2018.

Julphar is considering a group of deals in the Middle East and Africa, the Abu Dhabi-listed company’s general manager Jerome Carle told Bloomberg.  

The combined value of these deals could reach $50 million, Carle added, noting that his company may resort to securing finance from commercial banks.

The company focuses on the Middle East and North Africa (MENA), but it also considers potential deals in West and East Africa and opening new markets in South East Asia, the top official said, as Bloomberg reported.